National Institutes of Health / National Eye Institute (HHS)
Venture Capital
Part of National Institutes of Health
The National Eye Institute (NEI) is a component of the U.S. National Institutes of Health that leads federal investment in vision research and provides SBIR/STTR grants to small businesses developing innovative ophthalmic products, surgical instruments, diagnostics, and therapies with strong commercialization potential.
Pre-Seed
Seed
biotechnology
eye care
medical devices
ophthalmology
vision research
- Headquarters
- Bethesda, United States
- Founded
- 1968
- Website
- nei.nih.gov
- Total Investments
- 2
- Last Investment
- Mar 2025
- Geographic Focus
- United States
Investment Thesis
Fund early-stage R&D through SBIR (Phase I up to $295,924 total costs; Phase II up to $1,972,828 total costs) and STTR grants to small U.S. businesses working on innovations in vision and eye disease that have strong science and high commercialization potential.
National Institutes of Health / National Eye Institute (HHS) is a Venture Capital firm based in Bethesda, United States. It has made 2 investments in biotechnology and eye care.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account